Preparation of realgar nanoparticle suspension and its inhibition effect on the proliferation of human myelocytic leukaemia HL-60 cells

Journal of Dispersion Science and Technology

Volumn 30, Issue 2, 2009, Pages 237-240

  Wang, Nan ^a   Wang, Li Wen ^b   Gou, Bao Di ^a   Zhang, Tian Lan ^b  

^a PEKING UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

HL 60; Leukaemia; Nano particle; Proliferation; Realgar

Indexed keywords

ARSENIC COMPOUNDS; CALCIUM ION SENSORS; CELL PROLIFERATION;

CLINICAL EFFECTIVENESS; HL-60; LEUKAEMIA; MECHANISTIC STUDIES; NANOPARTICLE SUSPENSION; POOR SOLUBILITIES; PROLIFERATION; REALGAR;

NANOPARTICLES;

EID: 59049089580     PISSN: 01932691     EISSN: 15322351     Source Type: Journal    
DOI: 10.1080/01932690802501691     Document Type: Article

References (18)

1. Ni, D. and Sadler, P. J. (1991) Structure Bonding, 78, pp. 129-190.
2. Shen, L. S. (1996) Coloured Spectra of Traditional Chinese Medicines in "Shengnong Bencao Jing", China TCM Press, Beijing
3. Li, S. Z. (1975) "Bencao Gangmu" Recension, People's Medical Publishing House, Beijing
4. Meng, Z. Q. and Sun, E. J. (1996) Essential Elements in Life Sciences, China Metrology Press, Beijing
5. Zhang, T. D., Cheng, G. Q., Wang, Z. G., Wang, Z. Y., Chen, S. J. and Chen, Z. (2001) Oncogene, 20, pp. 7146-7153.
6. Miller Jr., W. H., Schipper, H. M., Lee, J. S., Singer, J. and Waxman, S. (2002) Cancer Res., 62, pp. 3893-3903.
7. Lu, D. P., Qiu, J. Y., Jiang, B., Wang, Q., Liu, K. Y., Liu, Y. R. and Chen, S. S. (2002) Blood, 99, pp. 3136-3143.
8. Wang, Z. Y. (2001) Cancer Chemother. Pharmacol., 48, pp. 72-76.
9. Gu, C. H. (2002) Acta Universitatis. Medicinalis. Secondae, 22, pp. 92-94.
10. Yuan, S. T., Zhang, G. Q. and Tian, S. Z. (1987) Bulletin. of Chinese. Material. Medica, 12, pp. 23-26.
11. Zhang, J. X., Yuan, S. T. and Zhang, G. Q. (1987) Bulletin. of Chinese. Material. Medica, 12, pp. 55-58.
12. Wang, X. B., Xi, R. G., Li, Z. L., Ren, R. M. and Huang, S. L. (2002) Pharm. J. Chin. PLA, 18, pp. 129-133.
13. Deng, Y., Xu, H., Huang, K., Yang, X., Xie, C. and Wu, J. (2001) Pharmacol. Res., 44, pp. 513-518.
14. Wu, J. Z. and Ho, P. C. (2006) Eur. J. Pharm. Scis., 29, pp. 35-44.
15. Hayao, I., Shinya, T., Noriko, S., Yoshirou, T. and Yoshihisa, S. (2002) J. Alloys Compounds, 330, pp. 579-583.
16. Lenoble, V., Deluchat, V., Serpaud, B. and Bollinger, J. (2003) Talanta, 61, pp. 267-276.
17. Jia, Y. M. and Liu, S. X. (2004) Chin. J. Prim. Med. Pharm., 11, pp. 138-139.
18. Wang, F. R., Luo, Y. Q. and Lu, D. P. (2005) Zhonghua. Nei. Ke. Za. Zhi., 44, pp. 730-733.